{
    "componentChunkName": "component---src-templates-event-registration-jsx",
    "path": "/events/will-the-government-commit-to-a-new-medicines-pledge",
    "result": {"data":{"markdownRemark":{"id":"5c200122-f515-5f9d-a289-49fd3a7895fa","frontmatter":{"name":"Will the next Government commit to a New Medicines Pledge?","slug":"will-the-government-commit-to-a-new-medicines-pledge","status":"past","eid":"13","colors":{"primary":"#1A2E59","secondary":"#025F9F","tertiary":"#A58A4B"},"title":"Will the next Government commit to a New Medicines Pledge?","subtitle":"A panel discussion","banner":null,"sponsor":{"name":"Vulcan Consulting","video":"","image":{"childImageSharp":{"gatsbyImageData":{"layout":"constrained","placeholder":{"fallback":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABQAAAAMCAYAAABiDJ37AAAACXBIWXMAAAsTAAALEwEAmpwYAAACTklEQVQoz6WQz0vUQRjGR81UoqIOlhm6IRp60NzddxaLbRHSSAIpiCCIfuy+I10sSt13yoOFBSWLrvsu3Qo8dBcsV+dLBO76Lh0Lgk5B/4gx60oS1aEGhmd+PZ/nfUcZq/cgwXMk6EAChQQ1Xv95VCGvkOCqsVoZq2tT6eh/AeeQYBYJ7iFBvBpQV9E07ARWpg/cvf9tJ0iwjASn0cIGElz4BVBp35BWyYlI5Tt89WOPYn+GIkEICfYhQTtaaKo+8pV2VytqNKRrkpPhijk1GVVjD/8OTCDBiCFtvKKFuCE9a0iPIMFdJLiCBGeQ4CkSXDSkM0gw6cN2wE54F9BCyFi9YkhfN1a/QKszhvS8sfoxks4Yq8NI2iLBG0P6tbH6lrH6CRIcvDM9oKYzozUe6Mq8Db423q2SU+FEcirckEpHziHBeWN19PZUGIzVg6l0dAgJtLHaa+zmg1OtN+73dqXS0fqtrS1V/rykCpL7CfzybXm71NZtuWTa1fhMorKeeDasmvuUumxCanzmrIqMKCWflkJfv789/P7jy2OF4nxdUM7Xv9tc8MBaJ9zgqR2FYja2vpnr8rpaXOhfK2UTa6XFRKGY1YVSdmB1Y75z5cNcy2pxoWd9MxdZKy3GnbB2wmEnPOiEo064PxCOqerhUSfc54RPOOFIIDwQCLcGko+6Mvc64SEn3OOEh6vmLv/GCSeccLMTjlfv21RQzu91wr1Bmfc74U4n+RYnuSYn3BRI/pDvwAl7PemEjzvhI94YCLc5qXganfABz3DCoz8AQvlACkF5IBMAAAAASUVORK5CYII="},"images":{"fallback":{"src":"/static/42885215c1ee6dd29e66da665fa4138c/8254c/sponsor.png","srcSet":"/static/42885215c1ee6dd29e66da665fa4138c/041be/sponsor.png 72w,\n/static/42885215c1ee6dd29e66da665fa4138c/ed18c/sponsor.png 145w,\n/static/42885215c1ee6dd29e66da665fa4138c/8254c/sponsor.png 289w","sizes":"(min-width: 289px) 289px, 100vw"},"sources":[{"srcSet":"/static/42885215c1ee6dd29e66da665fa4138c/ec5c5/sponsor.webp 72w,\n/static/42885215c1ee6dd29e66da665fa4138c/09cc2/sponsor.webp 145w,\n/static/42885215c1ee6dd29e66da665fa4138c/62cb3/sponsor.webp 289w","type":"image/webp","sizes":"(min-width: 289px) 289px, 100vw"}]},"width":289,"height":177}}},"description":"<strong>Vulcan Consulting is an award-winning public-affairs, government-relations and strategic-communications agency, based in both Dublin and Brussels. We specialise in providing our clients with best-in-class strategic advice on navigating the political and regulatory landscapes in Ireland and across Europe.</strong> <br /><br /> Founded in 2016 by CEO, Lucinda Creighton, a former Irish Minister for European Affairs, Vulcan aims to enhance and grow our clients’ public affairs and strategic communications objectives. Our team comprises former Ministers, parliamentarians, government advisors, parliamentary staff diplomats, civil servants, and policy and communications experts."},"speakers":[{"id":1,"name":"Lucinda Creighton","position":"Moderator","fbLink":"/","twLink":"/","linkedinLink":"/","emailLink":"/","shortSummary":"Chief Executive, Vulcan Consulting","summary":"Lucinda Creighton is a barrister, former Irish Minister for European Affairs and Member of the Irish Parliament. She is the founder and CEO of leading public affairs consultancy Vulcan Consulting (Dublin and Brussels).  <br /><br /> As Minister for European Affairs she represented­­ Ireland in key negotiations on the General Affairs Council of the EU, the Foreign Affairs Council of the EU, as well as multilateral fora such as the OSCE, ASEAN Foreign Ministers meetings and the Council of Europe. <br /><br /> She was also at the heart of the EU’s response to the global financial crisis alongside European Prime Ministers. She was engaged in negotiations on Ireland’s EU/IMF bailout and helped frame the EU’s institutional response to the euro crisis. <br /><br /> From 2012 to 2014 she also served as Vice President of the European People’s Party (EPP) and chaired the EPP European Affairs Ministers’ Council.  <br /><br /> Since founding Vulcan Consulting, Lucinda works closely with CEOs and senior management teams of global companies to assist them in understanding and navigating the political, policy and decision-making environment in Europe.   <br /><br /> Lucinda maintains a deep interest and expertise in Foreign Policy issues. Since 2017 she has served as the Senior Europe Advisor to the US NGO the Counter Extremism Project, focusing on security issues, violent extremism and terrorism. She is an Advisory Board member of the Washington DC based International Republican Institute (IRI) as well as being an active Council member of the European Council on Foreign Relations (ECFR). She is also a Non-resident Senior Fellow with the Digital Innovation Initiative at the Washington DC based think tank the Centre for European Policy Analysis (CEPA).","image":{"childImageSharp":{"gatsbyImageData":{"layout":"fullWidth","placeholder":{"fallback":"data:image/png;base64,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"},"images":{"fallback":{"src":"/static/18386d8e38266e6e01082a969c31f554/6c9d4/speaker-1.png","srcSet":"/static/18386d8e38266e6e01082a969c31f554/6c9d4/speaker-1.png 720w","sizes":"100vw"},"sources":[{"srcSet":"/static/18386d8e38266e6e01082a969c31f554/88c6b/speaker-1.webp 720w","type":"image/webp","sizes":"100vw"}]},"width":1,"height":1}}}},{"id":2,"name":"Vicky McGrath","position":"Guest","fbLink":"/","twLink":"/","linkedinLink":"/","emailLink":"/","shortSummary":"Chief Executive, Rare Diseases Ireland","summary":"Vicky McGrath is Chief Executive at Rare Diseases Ireland (RDI), the national alliance for rare disease patient organisations in Ireland. Vicky joined RDI as CEO in 2018 and has overseen development of the organisation into a strong and stable voice for people living with rare diseases in Ireland and their representative organisations, ensuring that rare voices are heard in the drive for equity - equitable access to diagnosis, treatment, health, social care and opportunity. <br /><br /> Over the course of Vicky’s tenure at RDI awareness of rare diseases has grown. This is true in particular at government/policy level as acknowledged in the 2020 Programme for Government, 2021 adoption of a UN Resolution on “Addressing the Challenges of Persons Living with a Rare Disease and their Families.” and 2022 support for development of an EU Action Plan on Rare Diseases. Vicky is a member of Irelands National Rare Disease Strategy and Implementation Plan Steering Group, established by the Department of Health in 2023, and co-chairs the Rare Disease Patient Forum at the Department. She is also representing the rare disease community on implementation of the HSE’s National Strategy for Accelerating Genetic and Genomic Medicine in Ireland.  <br /><br /> Vicky came to Rare Diseases Ireland from industry where she spent 20 years in various leadership roles within the life-sciences sector between the US and Ireland. She has a BE (Mechanical Engineering), an MSc (Biomedical Engineering), an MBA and is a fellow of BioInnovate Ireland.","image":{"childImageSharp":{"gatsbyImageData":{"layout":"fullWidth","placeholder":{"fallback":"data:image/png;base64,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"},"images":{"fallback":{"src":"/static/99bd6e741b3ea9df42a6243cbca47619/6c9d4/speaker-2.png","srcSet":"/static/99bd6e741b3ea9df42a6243cbca47619/6c9d4/speaker-2.png 720w","sizes":"100vw"},"sources":[{"srcSet":"/static/99bd6e741b3ea9df42a6243cbca47619/88c6b/speaker-2.webp 720w","type":"image/webp","sizes":"100vw"}]},"width":1,"height":1}}}},{"id":3,"name":"Eimear Caslin","position":"Guest","fbLink":"/","twLink":"/","linkedinLink":"/","emailLink":"/","shortSummary":"General Manager, GSK","summary":"With 30 years of experience in the pharmaceutical industry, Eimear has been the General Manager for GSK Ireland since 2017. She holds a Bachelor of Commerce, a Higher Diploma in Marketing Practice, a MSc in Strategic Management, and a Diploma in Company Direction. Eimear serves as a Director of GSK Ireland and is actively involved in the broader pharmaceutical community as a Board member and Deputy Vice President of the Irish Pharmaceutical Healthcare Association (IPHA). She also chairs IPHA’s Communication and Advocacy Forum and the Finance and HR Exchange group. Beyond her professional roles, Eimear is dedicated to giving back to the community. She has been a Board member of Barretstown Children’s Charity since 2022, contributing to their Risk and Governance committee since 2020.","image":{"childImageSharp":{"gatsbyImageData":{"layout":"fullWidth","placeholder":{"fallback":"data:image/png;base64,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"},"images":{"fallback":{"src":"/static/e583aabc6375e7a68767233c015a0ab6/6c9d4/speaker-3.png","srcSet":"/static/e583aabc6375e7a68767233c015a0ab6/6c9d4/speaker-3.png 720w","sizes":"100vw"},"sources":[{"srcSet":"/static/e583aabc6375e7a68767233c015a0ab6/88c6b/speaker-3.webp 720w","type":"image/webp","sizes":"100vw"}]},"width":1,"height":1}}}},{"id":4,"name":"Dr Austin Duffy","position":"Guest","fbLink":"/","twLink":"/","linkedinLink":"/","emailLink":"/","shortSummary":"Oncologist, Mater Hospital","summary":"Austin Duffy is a consultant medical oncologist at The Mater Hospital and associate Professor of Translational Oncology at UCD. In 2023 he became Director of Research for START Dublin, a tripartite partnership between The Mater, UCD and The START Center for Cancer Research to establish Ireland’s first dedicated site for phase 1 clinical trials in oncology. Between 2008 and 2017 Professor Duffy worked at the National Cancer Institute, USA where he developed and led over 25 early-phase clinical trials including the first-in-human combination of immune checkpoint inhibition with loco-regional treatment for hepatocellular carcinoma. In 2016 Professor Duffy was awarded a National Cancer Institute Director’s Award for Innovation in cancer research before returning to Ireland as a medical oncologist at the Mater Hospital. In October 2021 the National University of Ireland conferred the higher doctorate degree, Doctor of Medicine (DMed), on Professor Duffy in recognition of his internationally recognised research.","image":{"childImageSharp":{"gatsbyImageData":{"layout":"fullWidth","placeholder":{"fallback":"data:image/png;base64,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"},"images":{"fallback":{"src":"/static/40b09db3af32be44539c088200d5ddb3/6c9d4/speaker-4.png","srcSet":"/static/40b09db3af32be44539c088200d5ddb3/6c9d4/speaker-4.png 720w","sizes":"100vw"},"sources":[{"srcSet":"/static/40b09db3af32be44539c088200d5ddb3/88c6b/speaker-4.webp 720w","type":"image/webp","sizes":"100vw"}]},"width":1,"height":1}}}}],"socialThumbnail":{"childImageSharp":{"gatsbyImageData":{"layout":"fullWidth","placeholder":{"fallback":"data:image/png;base64,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"},"images":{"fallback":{"src":"/static/74f2547eced8abb55590ea52205f242a/b5380/social-thumbnail.png","srcSet":"/static/74f2547eced8abb55590ea52205f242a/5b584/social-thumbnail.png 750w,\n/static/74f2547eced8abb55590ea52205f242a/c1f05/social-thumbnail.png 1080w,\n/static/74f2547eced8abb55590ea52205f242a/b5380/social-thumbnail.png 1200w","sizes":"100vw"},"sources":[{"srcSet":"/static/74f2547eced8abb55590ea52205f242a/73e0d/social-thumbnail.webp 750w,\n/static/74f2547eced8abb55590ea52205f242a/9fede/social-thumbnail.webp 1080w,\n/static/74f2547eced8abb55590ea52205f242a/81547/social-thumbnail.webp 1200w","type":"image/webp","sizes":"100vw"}]},"width":1,"height":0.525}}},"bannerVideo":"/videos/event-1/banner-video.mp4","staticBannerImage":{"childImageSharp":{"gatsbyImageData":{"layout":"constrained","placeholder":{"fallback":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABQAAAALCAYAAAB/Ca1DAAAACXBIWXMAABYlAAAWJQFJUiTwAAACG0lEQVQoz2NgIAFc3reW8c3LBwxPXjySuLBq4reJuZH/S/LSrtZPmcic2dXHUFqURbxhtx8/Zzg0oZLx8IRqhgPTWmWO9JX+aPe3+p/harXh////DFMz45m8tOUJG3Th3j0G+6AghlU7djLcvHKGkU9ZnVFWTIjh8szKHR2BVv/jbQxDK9MSGN78/8+wbvd+RqIMBLkgJiOH4fLDhwyL9x1jWHvypvKSWVN2rK7L+J8QE/equKZ+8vlrN3QfffzCQLSBX/78Z9xy+LDEwzfv/Jev2/RtxsLl/5et3/yntLbpf1f/pP+t/ZPvO3j4cBE08PzduwwHzp9nOnTxIsPRK1dqDl++/H/B2g3/56/b+mfSgmX/N27f+XfSrLk/U0uq/le3d0cS5cLj164xnr5xk+HU5UviBy9d+Xjqwtn/PW1t/1r6Jv9btHzV/5zy6u9ROSU/C+tbjhJl4KPX75mef/rJ8OLDN7vzt+/93z+3/XdemM/vuIy83z2Tpv5PKSx/HJWetzq3ovYXQQPP3L7NcOXBU6aXX38xvP7xV3/DviNfyuqb/s9as+F/dXvP/95Z8/8nZOb99w2P/RWektlDVBoERcquUxcZ95+/xpDdNUNz19lrPZfvPZ64eMuu/t5Z8/sjvD0n+4RE9un4RPATbeCynQcY1h08wRhW0c5QNH0Zw7kHTxiW79jL0L1kDUNKSTWDf2wyg4SeOQMA8SEhoZutqLAAAAAASUVORK5CYII="},"images":{"fallback":{"src":"/static/0fed7974a39c37a3477f68897fa8e246/95497/static.png","srcSet":"/static/0fed7974a39c37a3477f68897fa8e246/fd4be/static.png 395w,\n/static/0fed7974a39c37a3477f68897fa8e246/1045c/static.png 790w,\n/static/0fed7974a39c37a3477f68897fa8e246/95497/static.png 1580w","sizes":"(min-width: 1580px) 1580px, 100vw"},"sources":[{"srcSet":"/static/0fed7974a39c37a3477f68897fa8e246/2aa88/static.webp 395w,\n/static/0fed7974a39c37a3477f68897fa8e246/c6d91/static.webp 790w,\n/static/0fed7974a39c37a3477f68897fa8e246/5e343/static.webp 1580w","type":"image/webp","sizes":"(min-width: 1580px) 1580px, 100vw"}]},"width":1580,"height":900}}},"description":"Medicines have a key role in people’s health and on the wider healthcare system. We are living in a fascinating era where medicines development is constantly changing and transforming how patients can be treated. However, patient care in Ireland is not as good as it could be because we do not have fast or fair access to new life-enhancing medicines and vaccines, as is the case in other European countries. <br /><br /> During the forthcoming General Election campaign IPHA are calling for a New Medicines Pledge to be adopted– where doctors can have the right medicine available for prescription for their patients at the right time; where the number of clinical trials in Ireland are doubled; and where patients with rare diseases have faster access to the medicines they need. <br /><br /> Join our panel of experts to hear what the next Government can do to ensure a continuous flow of new medicines for patients in Ireland and to learn more about the IPHA New Medicines Pledge.","date":"Thursday, November 14th 2024 <span>12pm - 1pm</span>","start":["Thursday, 14 November 2024 12:00:00 UTC"],"end":["Thursday, 14 November 2024 13:00:00 UTC"],"location":"Virtual Conference","startTime":"2024-11-14T012:00:00","endTime":"2024-11-14T013:00:00"}}},"pageContext":{"slug":"will-the-government-commit-to-a-new-medicines-pledge"}},
    "staticQueryHashes": ["1769874050","1786822504","2032888059","3155611666","3690355573"]}